■ 刊行論文
|
原著
|
|
1.
|
Mari Kihara, Takahiko Sugihara, Junichi Asano, Midori Sato, Hiroshi Kaneko, Sei Muraoka, Shiro Ohshima, Toshihiro Nanki：
Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry.
Clinical Rheumatology
41
(12)
：2661
-3673
, 2022
|
|
2.
|
Zento Yamada, Junko Nishio, Kaori Motomura, Satoshi Mizutani, Soichi Yamada, Tetuo Mikami, Toshihiro Nanki：
Senescence of alveolar epithelial cells impacts the initiation and chronic phase of murine fibrosing interstitial lung disease.
Frontiers in Immunology
13
：935114
, 2022
|
|
3.
|
Kawasaki A, Sada KE, Kusumawati PA, Hirano F, Kobayashi S, Nagasaka K, Sugihara T, Ono N, Fujimoto T, Kusaoi M, Tamura N, Kusanagi Y, Itoh K, Sumida T, Yamagata K, Hashimoto H, Makino H, Arimura Y, Harigai M, Tsuchiya N.：
Association of HLA-class II alleles with risk of relapse in myeloperoxidase-antineutrophil cytoplasmic antibody positive vasculitis in the Japanese population.
Frontiers in Immunology
14
：1119064
, 2023
|
|
4.
|
Kaneko K, Shikano K, Kawazoe M, Kawai S, Nanki T：
Efficacy of Denosumab for Osteoporosis in Patients with Rheumatic Diseases.
Internal medicine (Tokyo, Japan)
61
(16)
：2405
-2415
, 2022
|
|
5.
|
Toshihiro Nanki, Mai Kawazoe, Kiyoko Uno, Wataru Hirose, Hiroaki Dobashi, Hiroshi Kataoka, Toshihide Mimura, Hiroshi Hagino, Hajime Kono：
Improvement in glucocorticoid-induced osteoporosis on switching from bisphosphonates to once-weekly teriparatide: a randomized open-label trial.
Journal of Clinical Medicine
12
：292
, 2023
|
|
6.
|
Mai Kawazoe, Toshihiro Nanki, Noboru Hagino, Noriko Ikegaya, Satoshi Ito, Masanari Kodera, Naoko Nakano, Miki Suzuki, Shinya Kaname, Masayoshi Harigai：
Clinical characteristics of patients with polyarteritis nodosa based on a nationwide database in Japan.
Mod. Rheumatol
32
(3)
：598
-605
, 2022
|
|
7.
|
Kenji Nagasaka, Shinya Kaname, Koichi Amano, Masaru Kato, Yasuhiro Katsumata, Yoshinori Komagata, Ken-Ei Sada, Eiichi Tanaka, Naoto Tamura, Hiroaki Dobashi, Toshihiro Nanki, Yasuaki Harabuchi, Masashi Bando, Sakae Homma, Takashi Wada, Masayoshi Harigai：
Nation-wide survey of the treatment trend of microscopic polyangiitis and granulomatosis with polyangiitis in Japan using the Japanese Ministry of Health, Labour, and Welfare Database.
Modern Rheumatol
32
(5)
：915
-922
, 2022
|
|
8.
|
Naoto Tamura, Takanori Azuma, Kenta Misaki, Rei Yamaguchi, Fuminori Hirano, Eiji Sugiyama, Daisuke Kanai, Yohko Murakawa, Motohiro Oribe, Takahito Kimata, Kazutoshi Aoki, Tomoko Sugiura, Koji Takasugi, Yuya Takakubo, Yasuyuki Tomita, Takeo Isozaki, Toshihiro Nanki, Naooki Katsuyama, Takanori Kuroiwa, Hideto Oshikawa, Motohide Kaneko, Hiroshi Fujinaga, Kiwamu Saito, Eiichi Tanaka, Eisuke Inoue, Yuri Yoshizawa, Shigeru Matsumoto, Hisashi Yamanaka, Masayoshi Harigai：
Effectiveness and safety of subcutaneous abatacept in biologic-naïve RA patients at week 52: A Japanese multicenter investigational study (ORIGAMI Study).
Modern Rheumatology
32
(5)
：846
-856
, 2022
|
|
9.
|
Kawahito, Y., Morinobu, A., Kaneko, Y., Kohno, M., Hirata, S., Kishimoto, M., Seto, Y., Sugihara, T., Tanaka, E., Ito, H., Kojima, T., Matsushita, I., Nishida, K., Mori, M., Murashima, A., Yamanaka, H., Nakayama, T., Kojima, M. and Harigai, M：
Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication.
Modern Rheumatology
33
(1)
：21
-35
, 2023
|
|
10.
|
Ken-ei Sada, Kenji Nagasaka, Shinya Kaname, Tomoaki Higuchi, Shunsuke Furuta, Toshihiro Nanki, Naotake Tsuboi, Koichi Amano, Hiroaki Dobashi, Keiju Hiromura, Masashi Bando, Takashi Wada, Yoshihiro Arimura, Hirofumi Makino, Masayoshi Harigai, for the Research Committee of Intractable Vasculitis Syndrome (JPVAS) and Research Committee of Intractable Renal Disease of the Ministry of Health, Labour, and Welfare of Japan：
Evaluation of Ministry of Health, Labour and Welfare diagnostic criteria for antineutrophil cytoplasmic antibody-associated vasculitis compared to ACR/EULAR 2022 classification criteria.
Modern Rheumatology
：in press
, 2023
|
|
11.
|
Komiya Y, Sugihara T, Hirano F, Matsumoto T, Kamiya M, Sasaki H, et al.：
Factors associated with impaired physical function in elderly rheumatoid arthritis patients who had achieved low disease activity.
Modern Rheumatology
：
, 2023
|
|
12.
|
Eri Watanabe, Youhei Sugiyama, Hiroaki Sato, Toshiyuki Imanishi, Akinari Fukuda, Kenjiro Takagi, Tomoyuki Asano, Kiyoshi Migita, Toshihiro Nanki, Shigeru Kotake：
An adult-onset Still’s disease during pregnancy that delivered a neonate with hemophagocytic lymphohistiocytosis and severe liver failure requiring liver transplantation: A case report and literature review.
Modern Rheumatology Case Reports
6
(2)
：260
-265
, 2022
|
|
13.
|
Wataru Hirose, Masayoshi Harigai, Koichi Amano, Toshihiko Hidaka, Kenji Itoh, Kazutoshi Aoki, Masahiro Nakashima, Hayato Nagasawa, Yukiko Komano, Toshihiro Nanki：
Real-world effectiveness and safety of tofacitinib and abatacept in patients with rheumatoid arthritis.
Rheumatology Advance Practice
6
(3)
：rkac090
, 2022
|
|
総説及び解説
|
|
1.
|
南木敏宏：
関節リウマチと新型コロナウイルス感染症.
日本リウマチ友の会 東京支部だより116号
7957
：4
-6
, 2022
|
|
2.
|
南木敏宏：
治療法の再整理とアップデートのために 専門会による私の治療 悪性関節リウマチ.
日本医事新報
5146
：45
-46
, 2022
|
|
3.
|
川添麻衣、南木敏宏：
特集 血管炎の診療update-診断・治療の新展開-、Ⅳ. 最新の血管炎治療戦略、結節性多発動脈炎の診療ガイドライン.
日本臨牀
80
(8)
：1281
-1285
, 2022
|
|
4.
|
南木敏宏：
最新関節リウマチ学（第2版）。関節リウマチの治療、治療各論、開発中、申請中の生物学的抗リウマチ薬.
日本臨牀増刊号
80
(Suppl 4)
：437
-441
, 2022
|
|
5.
|
金子開知, 南木敏宏：
自己炎症性疾患の最前線。NLRC4異常症.
臨床免疫・アレルギー科
77
(6)
：690
-693
, 2022
|
|
